The antibody production market size is USD 16.8 Bn in 2026.
The antibody production market is projected to grow at about 7% CAGR by 2032.
The antibody production market growth drivers include rising chronic disease burden, single-use manufacturing systems, and increasing pharma R&D investments.
North America is a dominating region for the antibody production market.
Thermo Fisher Scientific, Danaher Corporation, GE Healthcare, Sartorius, and Merck KGaA are some leading industry players in the antibody production market.